Purchases and Sales Made in Q4 2022 in Vectiv Bio Holding Ag (VECT)
This table provides information about the institutional ownership of Vectiv Bio Holding Ag (VECT) during Q4 2022. The information is specifically focused on institutions that hold shares of VectivBio Holding AG.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2023
Q4 2022
|
Tcg Crossover Management, LLC
Palo Alto, CA |
BUY
|
- |
2.33MNew |
$18.2M - $21M
|
2.33M
$0
|
|
|
Feb 13, 2023
Q4 2022
|
Vivo Capital, LLC
Palo Alto, CA |
BUY
|
- |
2.33MNew |
$18.2M - $21M
|
2.33M
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Vr Adviser, LLC
New York, NY |
BUY
|
- |
1.87MNew |
$14.5M - $16.8M
|
1.87M
$0
|
|
|
Feb 13, 2023
Q4 2022
|
Chi Advisors LLC
New York, NY |
BUY
|
- |
1.37M+ 33.34% |
$10.7M - $12.3M
|
5.49M
$0
|
|
|
Feb 03, 2023
Q4 2022
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
BUY
|
- |
1.33MNew |
$10.4M - $12M
|
1.33M
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Blackstone Inc
New York, NY |
BUY
|
- |
1.33MNew |
$10.4M - $12M
|
1.33M
$0
|
|
|
Feb 13, 2023
Q4 2022
|
Eventide Asset Management, LLC
Boston, MA |
BUY
|
- |
1.07M+ 45.6% |
$8.31M - $9.58M
|
3.41M
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Marshall Wace, LLP
London, X0 |
BUY
|
- |
867K+ 172.48% |
$6.75M - $7.79M
|
1.37M
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Driehaus Capital Management LLC
Chicago, IL |
BUY
|
- |
862K+ 100.84% |
$6.71M - $7.74M
|
1.72M
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
823K+ 26.15% |
$6.41M - $7.39M
|
3.97M
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Orbimed Advisors LLC
San Diego, CA |
BUY
|
- |
533K+ 8.24% |
$4.15M - $4.79M
|
7.01M
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Pfm Health Sciences, LP
San Francisco, CA |
BUY
|
- |
25.5KNew |
$199K - $229K
|
25.5K
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Caxton Corp
Princeton, NJ |
BUY
|
- |
15.4K+ 10.9% |
$120K - $138K
|
156K
$0
|
|
|
Feb 13, 2023
Q4 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
4.19KNew |
$32.6K - $37.6K
|
4.19K
$0
|
|
|
Feb 10, 2023
Q4 2022
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
2.19K+ 99.36% |
$17K - $19.6K
|
4.39K
$0
|
|
|
Feb 13, 2023
Q4 2022
|
Barclays PLC
London, X0 |
BUY
|
- |
1.6K+ 20.49% |
$12.5K - $14.4K
|
9.41K
$0
|
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 09, 2023
Q4 2022
|
Citigroup Inc
|
SELL
|
- |
-300- 0.37% |
$2.34K - $2.69K
|
81.3K
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-4.68K- 19.56% |
$36.4K - $42K
|
19.2K
$0
|
|
|
Feb 08, 2023
Q4 2022
|
Ubs Group Ag
|
SELL
|
- |
-6.29K- 2.42% |
$49K - $56.5K
|
254K
$0
|
|
|
Feb 10, 2023
Q4 2022
|
Tekla Capital Management LLC
|
SELL
|
- |
-18.8K- 2.48% |
$146K - $169K
|
738K
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Balyasny Asset Management LLC
Chicago, IL |
SELL
|
- |
-19.3K- 5.31% |
$150K - $173K
|
343K
$0
|